Author
Qingyong Li
Also Known As
Qing-Yong Li, Qing-yong Li, QingYong Li, Qingyong Li, Qing‐yong Li
89
Publications
2K
Citations
22
H-Index
72
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 16 | 22 | 823 |
2 | Biochemistry | 9 | 9 | 245 |
3 | Engineering | 8 | 8 | 298 |
4 | Natural Sciences | 8 | 8 | 420 |
5 | Health Sciences | 3 | 3 | 59 |
Qingyong Li
×
43
Publications
1.6K
Citations
21
H-Index
| Year | Citations | |
|---|---|---|
Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer? Fengzhi Li, Tao Jiang, Qingyong Li, Cpt DerivativesTumor BiologyMedicinal ChemistryChemoprevention StrategyCpt Mechanism | 2017 | 225 |
2017 | 109 | |
2019 | 90 | |
2018 | 88 | |
2009 | 77 | |
2015 | 76 | |
2014 | 76 | |
2015 | 71 | |
2019 | 63 | |
2013 | 41 |
Page 1
Page 1